Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung ...

Fortune 500 companies represent two-thirds of the U.S. GDP with $18.8 trillion in revenues, $1.7 trillion in profits and $43 trillion in market value (as of March 28, 2024), and they employ 31 million ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Following the release of upbeat data and given some recent signs of stabilization in the stocks, MarketWatch took at look at companies in the healthcare sector that are expected to produce the fastest ...

The development of innovative pharmaceuticals targeting refractory mental health conditions has stagnated for decades. In recent years, ...

Reverend Bagaiya and His Royal Highness Gwamna Awan were quite close and were reported to have been associates of the duo of ...

We’re at the end of earnings season. That means it’s time for analysts to weigh in on the outlook for specific stocks. While there’s cautious optimism about how the second half of the year will go, ...

Chesley Taft & Associates trimmed its Johnson & Johnson stake by a modest 1.3%, but it still holds over $33 million in shares ...

US stocks finished in the red on Thursday as investors turned cautious ahead of the non-farm payrolls report, while shares in ...

Results from the Phase Ib/II CARTITUDE-1 trial demonstrated that a single infusion of Carvykti delivered durable, ...

Shares with over 50 years of consecutive dividend increases rarely go under the radar. But that might be what’s happening ...